Our Impact

We work tirelessly towards a world where people live longer, healthier lives from cancers prevented, caught early, or cured.

optimization-rocket-growthCreated with Sketch.


Investing in cutting-edge research to prevent, detect, and treat ovarian cancer, a deadly and underfunded disease.

Over $15.8 Million
to ovarian cancer researchers since 1999
232 Research Grants Funded
in areas of Prevention, Early Detection, Treatment, Survivorship
Large Applicant Pool

115 applicants each year for the past 5 years

15x Return on Investment

Rivkin-funded scientists receive 15x in new funding from other institutions after Rivkin’s initial investment

Our current funding rate is 8%, meaning we are leaving important science on the table. We want to see funding rates increase to 15% in two years.

people-woman-graduateCreated with Sketch.


Educating and empowering individuals to prevent and detect ovarian and breast cancer as early as possible.

Educated over 31k people

at 850 educational workshops in 6 states

40% of programming
to underserved & high-risk communities:
Low Income, Minority, LGBTQ+, Ashkenazi Jewish Heritage
Represented at all Pac-12 schools
95% of attendants
are likely or very likely to discuss health history with their family after attending party.

People assessed their risk for ovarian and breast cancer on Rivkin website in 2020. That’s up from 792 in 2018.

Group 15Created with Sketch.


Fostering an ever-growing community of survivors, patients, researchers, clinicians, and advocates.

32% increase in attendees
at Ovarian Cancer Research Symposium
(over 250 attendees)
1,000 SummeRun Participants

at the 2021 SummeRun & Walk

33 survivor-facilitators

in the education programs, up from 25 in 2016.

For more details and information on the Rivkin Center’s work in 2021: